Fulminant and fatal gas gangrene of the stomach in a healthy live liver donor.

PubWeight™: 1.44‹?› | Rank: Top 5%

🔗 View Article (PMID 15376309)

Published in Liver Transpl on October 01, 2004

Authors

Charles Miller1, Sander Florman, Leona Kim-Schluger, Patrick Lento, Julia De La Garza, Josephine Wu, Boxun Xie, Wandi Zhang, Edward Bottone, David Zhang, Myron Schwartz

Author Affiliations

1: Recanati / Miller Transplantation Institute, New York, NY, USA. drlivers@aol.com

Articles citing this

Laparoscopy-assisted hybrid left-side donor hepatectomy. World J Surg (2013) 2.02

Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90

Toward current standards of donor right hepatectomy for adult-to-adult live donor liver transplantation through the experience of 200 cases. Ann Surg (2007) 1.19

Live donors in liver transplantation. Gastroenterology (2008) 1.17

Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival. Ann Surg (2006) 1.06

Analysis of surgical and perioperative complications in seventy-five right hepatectomies for living donor liver transplantation. World J Gastroenterol (2008) 1.04

Current concept of small-for-size grafts in living donor liver transplantation. Surg Today (2008) 1.02

Gene-trap mutagenesis identifies mammalian genes contributing to intoxication by Clostridium perfringens ε-toxin. PLoS One (2011) 1.01

Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin. Infect Immun (2007) 0.95

Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients. World J Gastroenterol (2007) 0.94

Identification of amino acids important for binding of Clostridium perfringens epsilon toxin to host cells and to HAVCR1. Biochemistry (2012) 0.92

Adult-to-adult living donor liver transplantation. Can J Gastroenterol (2006) 0.90

Identification of Small Molecule Inhibitors of Clostridium perfringens ε-Toxin Cytotoxicity Using a Cell-Based High-Throughput Screen. Toxins (Basel) (2010) 0.88

Alterations in DNA gyrase and topoisomerase IV in resistant mutants of Clostridium perfringens found after in vitro treatment with fluoroquinolones. Antimicrob Agents Chemother (2005) 0.87

Oligomerization of Clostridium perfringens epsilon toxin is dependent upon caveolins 1 and 2. PLoS One (2012) 0.84

Living donor right liver lobe transplantation with or without inclusion of the middle hepatic vein: analysis of complications. World J Surg (2011) 0.83

Donor safety in live-related liver transplantation. Indian J Surg (2011) 0.82

Historical perspective of living donor liver transplantation. World J Gastroenterol (2008) 0.79

Donor selection for adult-to-adult living donor liver transplantation: well begun is half done. Transplantation (2013) 0.79

Living donor liver transplantation to patients with hepatitis C virus cirrhosis. World J Gastroenterol (2006) 0.79

Living donor liver transplantation in the USA. Hepatobiliary Surg Nutr (2016) 0.79

Predictors of donor follow-up after living donor liver transplantation. Liver Transpl (2014) 0.79

Comparison of right lobe donor hepatectomy with elective right hepatectomy for other causes in New York. Dig Dis Sci (2010) 0.77

Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon (2011) 0.77

Donor safety in adult living donor liver transplantation using the right lobe: single center experience in China. World J Gastroenterol (2007) 0.75

Living donor liver transplantation: eliminating the wait for death in end-stage liver disease? Nat Rev Gastroenterol Hepatol (2017) 0.75

Surviving emphysematous gastritis after hepatectomy. Case Reports Hepatol (2013) 0.75

Ethical tensions in solid organ transplantation: the price of success. World J Gastroenterol (2006) 0.75

Beta Lactamase Producing Clostridium perfringens Bacteremia in an Elderly Man with Acute Pancreatitis. Case Rep Crit Care (2016) 0.75

Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide. PLoS One (2015) 0.75

Long term follow-up and outcome of liver transplantation from hepatitis B surface antigen positive donors. World J Gastroenterol (2017) 0.75

Acute Necrotizing Cholangiohepatitis With Clostridium perfringens: A Rare Cause of Post-Transplantation Mortality. Gastroenterol Hepatol (N Y) (2010) 0.75

Highly sensitive sandwich immunoassay and immunochromatographic test for the detection of Clostridial epsilon toxin in complex matrices. PLoS One (2017) 0.75

Articles by these authors

Sorafenib in advanced hepatocellular carcinoma. N Engl J Med (2008) 54.30

Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst (2008) 11.27

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell (2013) 9.24

Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med (2008) 9.20

Resection of hepatocellular cancer ≤2 cm: results from two Western centers. Hepatology (2013) 5.05

Two-dimensional PCA: a new approach to appearance-based face representation and recognition. IEEE Trans Pattern Anal Mach Intell (2004) 4.92

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum (2012) 4.80

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum (2010) 4.57

Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis (2005) 4.51

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology (2009) 4.50

Focal gains of VEGFA and molecular classification of hepatocellular carcinoma. Cancer Res (2008) 4.35

Pivotal role of mTOR signaling in hepatocellular carcinoma. Gastroenterology (2008) 4.03

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology (2007) 3.85

The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res (2009) 3.18

Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol (2009) 2.42

Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology (2006) 2.32

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology (2004) 2.29

Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 2.29

Hepatitis C-related hepatocellular carcinoma in the United States: influence of ethnic status. Am J Gastroenterol (2003) 2.18

FSIM: a feature similarity index for image quality assessment. IEEE Trans Image Process (2011) 2.13

A completed modeling of local binary pattern operator for texture classification. IEEE Trans Image Process (2010) 2.00

Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation while reducing differentiation. J Hepatol (2006) 1.98

MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology (2011) 1.77

Reversal of in situ T-cell exhaustion during effective human antileukemia responses to donor lymphocyte infusion. Blood (2013) 1.67

IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage. J Hepatol (2010) 1.66

Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol (2013) 1.65

Globally maximizing, locally minimizing: unsupervised discriminant projection with applications to face and palm biometrics. IEEE Trans Pattern Anal Mach Intell (2007) 1.62

An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity. Nat Struct Mol Biol (2011) 1.58

Recurrence of hepatocellular cancer after resection: patterns, treatments, and prognosis. Ann Surg (2015) 1.53

Wrist pulse signal diagnosis using modified Gaussian models and Fuzzy C-Means classification. Med Eng Phys (2009) 1.53

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol (2002) 1.52

Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology (2009) 1.48

The beneficial impact of temporary porto-caval shunt in orthotopic liver transplantation: a single center analysis. Transpl Int (2010) 1.48

Intrahepatic cholangiocarcinoma: new insights in pathology. Semin Liver Dis (2011) 1.46

De novo hepatocellular carcinoma occurring in a transplanted liver: case report and review of the literature. Dig Dis Sci (2006) 1.45

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib. Clin Cancer Res (2012) 1.44

Noncomposite simultaneous liver and intestinal transplantation. Transplantation (2003) 1.43

Contactless and pose invariant biometric identification using hand surface. IEEE Trans Image Process (2011) 1.43

Personal recognition using hand shape and texture. IEEE Trans Image Process (2006) 1.42

Potentiation of acetaminophen hepatotoxicity by phenytoin, leading to liver transplantation. Dig Dis Sci (2005) 1.41

Characteristics of diabetes after pediatric liver transplant. Pediatr Transplant (2012) 1.39

Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. J Pharmacol Exp Ther (2002) 1.39

KPCA plus LDA: a complete kernel Fisher discriminant framework for feature extraction and recognition. IEEE Trans Pattern Anal Mach Intell (2005) 1.37

Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg (2004) 1.36

The bi-elliptical deformable contour and its application to automated tongue segmentation in Chinese medicine. IEEE Trans Med Imaging (2005) 1.33

Evidence for ineffective erythropoiesis in severe sickle cell disease. Blood (2005) 1.31

Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies. Transplantation (2010) 1.28

Stable long-term donor engraftment following reduced-intensity hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant (2008) 1.27

The crosstalk between EGF, IGF, and Insulin cell signaling pathways--computational and experimental analysis. BMC Syst Biol (2009) 1.24

Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients. Pediatr Transplant (2013) 1.21

Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res (2003) 1.20

Early and mid-term results of off-pump endarterectomy of the left anterior descending artery. Interact Cardiovasc Thorac Surg (2012) 1.20

An optimized tongue image color correction scheme. IEEE Trans Inf Technol Biomed (2010) 1.19

Post-liver transplant acute renal failure: factors predicting development of end-stage renal disease. Clin Transplant (2004) 1.17

Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother (2004) 1.16

Geographic disparity: the dilemma of lower socioeconomic status, multiple listing, and death on the liver transplant waiting list. Clin Transplant (2014) 1.14

A face and palmprint recognition approach based on discriminant DCT feature extraction. IEEE Trans Syst Man Cybern B Cybern (2004) 1.14

MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidates. Gastroenterology (2009) 1.11

Automated tongue segmentation in hyperspectral images for medicine. Appl Opt (2007) 1.11

Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. J Clin Invest (2012) 1.09

Feasibility and preliminary accuracy of high-resolution imaging of the liver and pancreas using FNA compatible microendoscopy (with video). Gastrointest Endosc (2012) 1.09

Intravascular epithelioid hemangioendothelioma of the inferior vena cava: case report of an unusual and unpredictable vascular tumor. Cardiovasc Pathol (2008) 1.09

Characterization of palmprints by wavelet signatures via directional context modeling. IEEE Trans Syst Man Cybern B Cybern (2004) 1.08

Efficacious immune therapy in chronic myelogenous leukemia (CML) recognizes antigens that are expressed on CML progenitor cells. Cancer Res (2010) 1.08

FoxM1 is associated with poor prognosis of non-small cell lung cancer patients through promoting tumor metastasis. PLoS One (2013) 1.06

Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol (2008) 1.05

Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response. J Clin Invest (2012) 1.04

Classification of hyperspectral medical tongue images for tongue diagnosis. Comput Med Imaging Graph (2007) 1.04

Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens. Cancer Res (2010) 1.04

Surgical dilemma: liver resection or liver transplantation for hepatocellular carcinoma and cirrhosis. Intention-to-treat analysis in patients within and outwith Milan criteria. HPB (Oxford) (2009) 1.02

Interlaboratory transfer of a PCR multiplex method for simultaneous detection of four genetically modified maize lines: Bt11, MON810, T25, and GA21. J Agric Food Chem (2005) 1.02

Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl (2009) 1.02

Anticancer activity of Scutellaria baicalensis and its potential mechanism. J Altern Complement Med (2002) 1.01

Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans. J Clin Invest (2011) 1.01

Isolated intestinal transplantation: proof of clinical efficacy. Transplantation (2003) 1.00

Second hepatic resection for recurrent hepatocellular cancer: a Western experience. J Hepatol (2010) 1.00

Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Ann Surg (2014) 0.99

Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99

Wavelet-based cascaded adaptive filter for removing baseline drift in pulse waveforms. IEEE Trans Biomed Eng (2005) 0.99

Baseline wander correction in pulse waveforms using wavelet-based cascaded adaptive filter. Comput Biol Med (2006) 0.99

Statistical analysis of tongue images for feature extraction and diagnostics. IEEE Trans Image Process (2013) 0.99

Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div (2009) 0.99

Computerized tongue diagnosis based on Bayesian networks. IEEE Trans Biomed Eng (2004) 0.96

Detection and toxin typing of Clostridium perfringens in formalin-fixed, paraffin-embedded tissue samples by PCR. J Clin Microbiol (2008) 0.96

Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist (2005) 0.96

Frequency of douching and risk of bacterial vaginosis in African-American women. Obstet Gynecol (2004) 0.96

SimBoolNet--a Cytoscape plugin for dynamic simulation of signaling networks. Bioinformatics (2009) 0.95

Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One (2012) 0.95

Liver transplantation in children weighing 5 kg or less: analysis of the UNOS database. Pediatr Transplant (2011) 0.94

Enantioselective ruthenium-catalyzed carbonyl allylation via alkyne-alcohol C-C bond-forming transfer hydrogenation: allene hydrometalation vs oxidative coupling. J Am Chem Soc (2015) 0.93

Natura-alpha targets forkhead box m1 and inhibits androgen-dependent and -independent prostate cancer growth and invasion. Clin Cancer Res (2011) 0.93

Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon. Virol J (2007) 0.93

Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93